BIOTRANSFORMATION OF PRAVASTATIN SODIUM(I) - MECHANISMS OF ENZYMATIC TRANSFORMATION AND EPIMERIZATION OF AN ALLYLIC HYDROXY GROUP OF PRAVASTATIN SODIUM

被引:38
作者
KITAZAWA, E
TAMURA, N
IWABUCHI, H
UCHIYAMA, M
MURAMATSU, S
TAKAHAGI, H
TANAKA, M
机构
[1] Analytical and Metabolic Research Laboratories, Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140, 2-58
关键词
D O I
10.1006/bbrc.1993.1457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the major metabolites, R-416(3′α-OH), of pravastatin sodium(PV, 6′β-OH), and a minor metabolite, R-418(6′α-OH), were produced in rat liver cytosol in the presence of adenosine 3′-phosphate 5′-phosphosulfate as a cofactor. The reactions were inhibited by the inhibitors for sulfotransferases, and 18OH was introduced to the 3′α- and 6′α-positions of R-416 and R-418, respectively, by incubation with H2 18O. These results strongly suggested that PV was metabolically activated by sulfation at the 6′β-hydroxy group by sulfotransferases, followed by nucleophilic attack of hydroxy anions at the 3′α- or 6′α-position, to give R-416 or R-418, respectively. © 1993 Academic Press.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 13 条
[1]  
ARAI M, 1988, ANN REP SANKYO RES L, V40, P1
[2]  
EVERETT DW, 1991, DRUG METAB DISPOS, V19, P740
[3]   TISSUE SELECTIVITY OF PRAVASTATIN SODIUM, LOVASTATIN AND SIMVASTATIN - THE RELATIONSHIP BETWEEN INHIBITION OF DENOVO STEROL SYNTHESIS AND ACTIVE-DRUG CONCENTRATIONS IN THE LIVER, SPLEEN AND TESTIS IN RAT [J].
KOGA, T ;
FUKUDA, K ;
SHIMADA, Y ;
FUKAMI, M ;
KOIKE, H ;
TSUJITA, Y .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 209 (01) :315-319
[4]   CARRIER-MEDIATED UPTAKE OF PRAVASTATIN BY RAT HEPATOCYTES IN PRIMARY CULTURE [J].
KOMAI, T ;
SHIGEHARA, E ;
TOKUI, T ;
KOGA, T ;
ISHIGAMI, M ;
KUROIWA, C ;
HORIUCHI, S .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (04) :667-670
[5]   METABOLISM OF PRAVASTATIN SODIUM IN ISOLATED RAT HEPATOCYTES .1. GLUTATHIONE CONJUGATE FORMATION REACTION [J].
MURAMATSU, S ;
MIYAGUCHI, K ;
IWABUCHI, H ;
MATSUSHITA, Y ;
NAKAMURA, T ;
KINOSHITA, T ;
TANAKA, M ;
TAKAHAGI, H .
XENOBIOTICA, 1992, 22 (05) :487-498
[6]   A HYDROXYMETHYL SULFATE ESTER AS AN ACTIVE METABOLITE OF THE CARCINOGEN, 5-HYDROXYMETHYLCHRYSENE [J].
OKUDA, H ;
HIRATSUKA, A ;
NOJIMA, H ;
WATABE, T .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (03) :535-538
[7]  
Sasahara K., 1988, J CLIN THER MED, V4, P45
[8]   6-ALPHA-HYDROXY-ISO-ML-236B (6-ALPHA-HYDROXY-ISO-COMPACTIN) AND ML-236A, MICROBIAL TRANSFORMATION PRODUCTS OF ML-236B [J].
SERIZAWA, N ;
NAKAGAWA, K ;
TSUJITA, Y ;
TERAHARA, A ;
KUWANO, H ;
TANAKA, M .
JOURNAL OF ANTIBIOTICS, 1983, 36 (07) :918-920
[9]   HEPATIC DNA AND RNA ADDUCT FORMATION FROM THE CARCINOGEN 7-HYDROXYMETHYL-12-METHYLBENZ[A]ANTHRACENE AND ITS ELECTROPHILIC SULFURIC-ACID ESTER METABOLITE IN PREWEANLING RATS AND MICE [J].
SURH, YJ ;
LAI, CC ;
MILLER, JA ;
MILLER, EC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 144 (02) :576-582
[10]   CS-514, A COMPETITIVE INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE - TISSUE-SELECTIVE INHIBITION OF STEROL SYNTHESIS AND HYPOLIPIDEMIC EFFECT ON VARIOUS ANIMAL SPECIES [J].
TSUJITA, Y ;
KURODA, M ;
SHIMADA, Y ;
TANZAWA, K ;
ARAI, M ;
KANEKO, I ;
TANAKA, M ;
MASUDA, H ;
TARUMI, C ;
WATANABE, Y ;
FUJII, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 877 (01) :50-60